Craniofacial Microsomia: Accelerating Understanding of the Significance and Etiology

CompletedOBSERVATIONAL
Enrollment

935

Participants

Timeline

Start Date

February 23, 2018

Primary Completion Date

November 30, 2021

Study Completion Date

August 30, 2023

Conditions
MicrotiaMicrotia-AnotiaCraniofacial MicrosomiaGoldenhar SyndromeOAVSOAV SyndromeHemifacial Microsomia
Trial Locations (10)

27599

University of North Carolina, Chapel Hill

90027

Children's Hospital Los Angeles, Los Angeles

Children's Hospital of Philadelphia, Philadelphia

98101

Seattle Children's Hospital, Seattle

Unknown

Pontificia Universidad Javeriana, Bogotá

Clínica Comfamiliar Risaralda, Pereira

ICESI, Santiago de Cali

Pontificia Universidad Javeriana, Santiago de Cali

Hospital Edgardo Rebagliati Martins, Lima

Instituto de Genética Médica y Molecular (INGEMM), Madrid

All Listed Sponsors
collaborator

Children's Hospital Los Angeles

OTHER

collaborator

Children's Hospital of Philadelphia

OTHER

collaborator

University of North Carolina, Chapel Hill

OTHER

collaborator

Pontificia Universidad Javeriana

OTHER

collaborator

Universidad Icesi

OTHER

collaborator

Hospital Nacional Edgardo Rebagliati Martins

OTHER

collaborator

Instituto de Investigación Hospital Universitario La Paz

OTHER

collaborator

Clinica Comfamiliar Risaralda

UNKNOWN

lead

Seattle Children's Hospital

OTHER

NCT04351893 - Craniofacial Microsomia: Accelerating Understanding of the Significance and Etiology | Biotech Hunter | Biotech Hunter